Cancers with RAD51 foci deficiency had significantly higher HRDetect scores than tumour samples that were RAD51 foci proficient (n = 18, p = 0.0146 Mann–Whitney test; Fig. 3c). This evidence concerns the gene RAD51 and cancer.